• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Stem Cell Therapy for Aortic Aneurysm

Research Project

Project/Area Number 25462161
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Research Field Cardiovascular surgery
Research InstitutionNagoya University

Principal Investigator

Narita Yuji  名古屋大学, 医学(系)研究科(研究院), 講師 (60378221)

Co-Investigator(Kenkyū-buntansha) USUI AKIHIKO  名古屋大学, 医学系研究科, 教授 (30283443)
OSHIMA HIDEKI  名古屋大学, 医学部附属病院, 講師 (40378188)
OGATA AIKA  名古屋大学, 医学系研究科, 研究員 (70718311)
OKADA MASAHO  名古屋大学, 医学部附属病院, 病院助教 (20566989)
Project Period (FY) 2013-04-01 – 2016-03-31
Project Status Completed (Fiscal Year 2015)
Budget Amount *help
¥5,070,000 (Direct Cost: ¥3,900,000、Indirect Cost: ¥1,170,000)
Fiscal Year 2015: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2014: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2013: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
Keywords大動脈瘤 / 細胞療法 / 間葉系幹細胞 / 同種移植 / リバースリモデリング / エラスチン / 抗炎症作用 / 免疫抑制能 / マクロファージ / マトリクスメタロプロテアーゼ / 炎症性サイトカイン
Outline of Final Research Achievements

We have reported intravenous administration of bone marrow-derived mesenchymal stem cells (BM-MSCs) reduce the incidence of aortic aneurysm. However, optimal injected cell number, injected interval, timing of administration and optimal cell sources were unknown. In this study, we tried to explore optimal stem cell therapy for aortic aneurysm.
Intravenous administration of BM-MSCs not only prevented growth of aortic aneurysm, but conducted regression of aortic aneurysm. The aortic aneurysm was prevented by every 4 weeks administration of BM-MSC, however, it could not achieve by single administration. The regression of aortic aneurysm was maintained until 2 weeks after administration of BM-MSCs. The administration of BM-MSCs was better for regression of the aortic aneurysm than that of adipocyte-derived MSCs or fibroblast. The administration of allogenic BM-MSCs was effective treatment for aortic aneurysm as same as that of autologous BM-MSCs.

Report

(3 results)
  • 2015 Annual Research Report   Final Research Report ( PDF )
  • 2013 Research-status Report
  • Research Products

    (8 results)

All 2016 2014 2013 Other

All Journal Article (2 results) (of which Peer Reviewed: 2 results) Presentation (5 results) Remarks (1 results)

  • [Journal Article] Therapeutic potential of bone marrow-derived mesenchymal stem cells in formed aortic aneurysm of mouse model.2014

    • Author(s)
      Yamawaki-Ogata A, Fu XM, Hashizume R, Araki Y, Oshima H, Narita Y, Usui A.
    • Journal Title

      Eur J Cardiothorac Surg

      Volume: 45 Issue: 5 Pages: e156-e165

    • DOI

      10.1093/ejcts/ezu018

    • Related Report
      2013 Research-status Report
    • Peer Reviewed
  • [Journal Article] Intravenous administration of mesenchymal stem cells prevent angiotensin II-induced aortic aneurysm formation in apolipoprotein E-deficient mouse.2013

    • Author(s)
      Fu XM, Yamawaki-Ogata A, Oshima H, Ueda Y, Usui A, Narita Y.
    • Journal Title

      J Transl Med

      Volume: 11 Issue: 1 Pages: 175-175

    • DOI

      10.1186/1479-5876-11-175

    • Related Report
      2013 Research-status Report
    • Peer Reviewed
  • [Presentation] 大動脈瘤に対する幹細胞療法 効果のメカニズムに関して2016

    • Author(s)
      成田裕司
    • Organizer
      第46回日本心臓血管外科学会学術総会
    • Place of Presentation
      名古屋国際会議場(愛知県名古屋市)
    • Year and Date
      2016-02-15
    • Related Report
      2015 Annual Research Report
  • [Presentation] Stem cell therapy for treatment of aortic aneurysm in mice.

    • Author(s)
      Narita Y, Yamawaki-Ogata A, Fu X, Araki Y, Oshima H, Usui A.
    • Organizer
      27th European Association for Cardio-Thoracic Surgery
    • Place of Presentation
      Vienna, Austria
    • Related Report
      2013 Research-status Report
  • [Presentation] 大動脈瘤に対する細胞治療 -細胞源による治療効果の比較-

    • Author(s)
      緒方藍歌、成田裕司、荒木善盛、大島英揮、碓氷章彦.
    • Organizer
      第13回日本再生医療学会総会
    • Place of Presentation
      国立京都国際会館、京都市
    • Related Report
      2013 Research-status Report
  • [Presentation] 大動脈瘤に対する幹細胞療法 ー投与法による大動脈瘤進展抑制効果の違いー

    • Author(s)
      成田裕司、緒方藍歌、符 顕明、荒木善盛、阿部知伸、大島英揮、碓氷章彦.
    • Organizer
      第44回日本心臓血管外科学会
    • Place of Presentation
      ホテル日航熊本、熊本市
    • Related Report
      2013 Research-status Report
  • [Presentation] 大動脈瘤に対する間葉系幹細胞の静注療法

    • Author(s)
      成田裕司、緒方藍歌、符 顕明、大島英揮、碓氷章彦.
    • Organizer
      第66回日本胸部外科学会
    • Place of Presentation
      仙台国際センター、仙台市
    • Related Report
      2013 Research-status Report
  • [Remarks] 名古屋大学大学院医学系研究科心臓外科学 研究について

    • URL

      http://www.med.nagoya-u.ac.jp/shinzougeka/about/research.html

    • Related Report
      2013 Research-status Report

URL: 

Published: 2014-07-25   Modified: 2019-07-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi